Taking Stock

As an ardent follower of the recent advances in the understanding and treatment of migraine disorders I am impressed with the great strides made over the last 24 months. It is remarkable that since the 1990s and the introduction of triptans, so much significant work in both prevention and treatment is now coming to fruition. So why now? What forces conspired to move the migraine agenda forward? I think it is important that we look at this question in an effort to ascertain why these positive results have occurred and our agenda has continued to gain traction.

Traumatic Brain Injuries and Migraines

Traumatic Brain Injury and Migraines: Civilian and Military Implications

Consideration of this subject brings us to the intersection of some of the most critical issues challenging the migraine treatment community. With Memorial Day fading in the rear view mirror, we at AMD began to reflect on a number of these issues and thought looking at Traumatic Brain Injury (TBI) may be as good a place as any to enter the ongoing controversy. Yes, TBI, because of its startling presence in both the military and civilian worlds, TBI could prove a very opportune place indeed.

Headache on the Hill (HOH) 2016

This is an annual event, organized by the nonprofit Alliance for Headache Disorders Advocacy (AHDA), to advocate on behalf of Americans with disabling headache disorders. This is primarily a grassroots advocacy for increased funding of headache research. Its founder and thought-leader is Robert E. Shapiro, MD, PhD and its president is William B. Young, MD. AHDA is supported by a confederation of nonprofit headache organizations.